COMMUNIQUÉS West-GlobeNewswire

IBEX Grants Stock Options and Amends Incentive Stock Option Plan

20/12/2017 - 14:00

MONTREAL, Dec. 20, 2017 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX-V: IBT ) announces that on December 19, 2017, its Board of Directors granted an aggregate of 675,000 stock options to [...]

AzurRx BioPharma Announces Publication of U.S. Patent Application for AZX1101

20/12/2017 - 13:30

BROOKLYN, N.Y., Dec. 20, 2017 (GLOBE NEWSWIRE) -- AzurRx BioPharma Inc.(NASDAQ: AZRX ) (“AzurRx” or the “Company”), today announced that the United States Patent and Trademark Office has published patent application [...]

New Member appointed to the Board of Directors of Neuralstem

20/12/2017 - 13:30

GERMANTOWN, Md., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq: CUR ), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that Xi Chen, Ph.D., has been [...]

Hemostemix Receives Health Canada Clearance to Continue with Critical Limb Ischemia Clinical Trials

20/12/2017 - 13:30

CALGARY, Alberta, Dec. 20, 2017 (GLOBE NEWSWIRE) -- Hemostemix Inc . (“ Hemostemix ” or the “ Company ”) (TSX VENTURE:HEM) announced today that they have received a No Objection Letter from Health Canada for its current [...]

K2M Introduces World’s First 3D-Printed Expandable Corpectomy Cage with Cervical Spine Indications Following CE Mark of CAPRI® Cervical 3D Expandable Featuring Lamellar 3D Titanium Technology™

20/12/2017 - 13:01

LEESBURG, Va., Dec. 20, 2017 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ: KTWO ) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three- [...]

Loxo Oncology Initiates Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Larotrectinib for the Treatment of TRK Fusion Cancers

20/12/2017 - 12:45

STAMFORD, Conn., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq: LOXO ), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers [...]

Avivagen Inc. Announces Results for Fiscal Year Ending October 31, 2017

20/12/2017 - 12:30

OTTAWA, Dec. 20, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSX-V: VIV ) (OTC Pink:CHEXF) (“ Avivagen ” or the “ Company ”), a life sciences innovation company with a series of patent protected products that support and [...]

Achillion Initiates Phase I First-In Study of ACH-5228, a Next-Generation Oral Small Molecule Inhibitor of Complement Factor D

20/12/2017 - 12:05

NEW HAVEN, Conn., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN ), a pharmaceutical company focused on advancing small molecule inhibitors of factor D in the complement alternative [...]

Mesoblast’s Phase 3 Trial in Children With Acute Graft Versus Host Disease Completes Enrollment

20/12/2017 - 12:00

NEW YORK and MELBOURNE, Australia, Dec. 20, 2017 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq: MESO ) (ASX:MSB) today announced that the Phase 3 trial of its proprietary allogeneic mesenchymal stem cell (MSC) product [...]

Changes to the Executive Leadership Team

20/12/2017 - 11:59

Novozymes announces the appointment of Ms. Prisca Havranek-Kosicek as new Chief Financial Officer effective February 1, 2018. Ms. Havranek-Kosicek has up until November 2017 served as CFO and member of the Executive [...]

Adventist Health Promotes Joe Reppert as Chief Financial Officer

20/12/2017 - 11:30

ROSEVILLE, Calif., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Adventist Health —a non-profit integrated health system serving more than 75 communities on the West Coast and in Hawaii—is proud to announce the recent promotion of [...]

ALK – Financial calendar for the 2018 financial year

20/12/2017 - 11:06

Copenhagen, 2017-12-20 11:06 CET (GLOBE NEWSWIRE) -- 2018 financial calendar for ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ): Silent period 9 January 2018 Annual report 2017 6 February 2018 Annual General Meeting to be [...]

NeuroSearch – financial calendar for 2018

20/12/2017 - 08:00

Announcement no. 9-17 Page 1 of 1 Announcement 20 December 2017 NeuroSearch A/S (NEUR) hereby announces the company’s financial calendar for 2018. 9 February 2018 Annual Report 2017 25 April 2018 Annual General Meeting [...]

TiGenix confirms strategic focus on Cx601 and its adipose derived stem cell (eASC) platform

20/12/2017 - 07:01

PRESS RELEASE TiGenix confirms strategic focus on Cx601 and its adipose derived stem cell (eASC) platform Leuven (BELGIUM) - December 20, 2017, 7:00h CET - TiGenix NV (Euronext Brussels and NASDAQ: TIG) ("TiGenix" or " [...]

TiGenix confirme l'orientation stratégique du Cx601 et de la plateforme de cellules souches dérivées de tissus adipeux (eASC)

20/12/2017 - 07:01

COMMUNIQUÉ DE PRESSE TiGenix confirme l'orientation stratégique du Cx601 et de la plateforme de cellules souches dérivées de tissus adipeux (eASC) Louvain (BELGIQUE) - 20 décembre 2017, 07h. CET - TiGenix NV (Euronext [...]

MPX Bioceutical Corporation Provides Update on Private Placement

20/12/2017 - 01:59

TORONTO, Dec. 19, 2017 (GLOBE NEWSWIRE) -- MPX Bioceutical Corp. (the “ Company ” or “ MPX ”) (CSE:MPX) (OTC:MPXEF) is pleased to provide this corporate update concerning its previously announced brokered private [...]

Skyline Medical Acquiring up to 25% Equity Stake in Helomics Corporation, a Precision Diagnostics Company

19/12/2017 - 23:30

MINNEAPOLIS, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc . (NASDAQ: SKLN ) (“Skyline” or the “Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, [...]

Catalyst Biosciences Announces Proposed Public Offering of Common Stock

19/12/2017 - 22:51

SOUTH SAN FRANCISCO, Calif., Dec. 19, 2017 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO ), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology [...]

ProPhase Labs, Inc. Announces Preliminary Results of Its Tender Offer

19/12/2017 - 22:30

DOYLESTOWN, Pa., Dec. 19, 2017 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH ) ( www.ProPhaseLabs.com ), a diversified natural health medical science company (“ProPhase”), announced today the preliminary results [...]